Floatz logo

Therapeutic Asset Ratings

5,108 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Treosulfan
Myelodysplastic Syndrome
Masonic Cancer Center, University of MinnesotaP3BB (68)
Valganciclovir
Cytomegalovirus Infection
The Methodist Hospital Research InstituteP3BB (68)
Venetoclax
Disease Related To Hematopoietic Stem Cell Transplant
The First Affiliated Hospital of Soochow UniversityP3BB (68)
Venetoclax
Myeloid Neoplasm
First Affiliated Hospital of Zhejiang UniversityP3BB (68)
(+)-VINCRISTINE
Glioblastoma
University of CincinnatiP3BB (68)
(+)-VINCRISTINE
Hodgkins Lymphoma
National Research Center for Hematology, RussiaP3BB (68)
(+)-VINCRISTINE
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP3BB (68)
VINCRISTINE SULFATE
Adult Acute Lymphoblastic Leukemia
University of WashingtonP3BB (68)
VINCRISTINE SULFATE
Splenic Marginal Zone Lymphoma
SWOG Cancer Research NetworkP3BB (68)
Vinorelbine
Lung Adenocarcinoma
AIO-Studien-gGmbHP3BB (68)
Vinorelbine
HER2 Positive Breast Carcinoma
Fudan UniversityP3BB (68)
Vinorelbine
Lung Cancer
Alliance for Clinical Trials in OncologyP3BB (68)
Zanubrutinib
Splenic Marginal Zone Lymphoma
SWOG Cancer Research NetworkP3BB (68)
Zorevunersen
Dravet Syndrome
Stoke Therapeutics, IncP3BB (68)
2-(P-(2-(P-CHLOROBENZAMIDO)ETHYL)PHENOXY)-2-METHYLPROPIONIC ACID
Primary Biliary Cholangitis
Intercept PharmaceuticalsP3BB (67)
Acetylsalicylic Acid
Cerebrovascular Disorder
Peking Union Medical College HospitalP3BB (67)
Alpelisib
Triple-Negative Breast Carcinoma
The Methodist Hospital Research InstituteP3BB (67)
ALTEPLASE
Basilar Artery Occlusion
The First Affiliated Hospital of University of Science and Technology of ChinaP3BB (67)
Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA) introduced transiently as ribonucleoprotein (RNP) complex, targeting the erythroid lineage-specific enhancer region of BCL11A (B-cell lymphoma/leukemia 11A). The site-specific cleavage by Cas9 forms a double strand break (DSB), which is subsequently repaired by nonhomologous end-joining (NHEJ), leading to the transcriptional repression of BCL11A, a repressor of ?-globin gene transcription
Thalassemia
Vertex Pharmaceuticals IncorporatedP3BB (67)
Avapritinib
Gastrointestinal Stromal Tumor
Blueprint Medicines CorporationP3BB (67)
Azetukalner
Focal Epilepsy
Xenon Pharmaceuticals Inc.P3BB (67)
BICALUTAMIDE
Triple-Negative Breast Carcinoma
Universitaire Ziekenhuizen KU LeuvenP3BB (67)
Blinatumomab
Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (67)
Blinatumomab
Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (67)
Brentuximab Vedotin
Primary Cutaneous Anaplastic Large Cell Lymphoma
John ReneauP3BB (67)
Showing 801 to 825 of 5,108 assets
PreviousPage 33 of 205Next